SteelSky Ventures, the world's leading women's health fund, has made a strategic investment in Posterity Health, a technology-driven platform focused on optimizing the fertility process. This investment represents a crucial step forward in taking a holistic approach to fertility care, as Posterity both improves fertility outcomes and benefits women by minimizing unnecessary invasive treatments and the high costs associated with IVF.

Fertility isn't just a women's issue. Fifty percent of infertility cases are male-driven, yet the current system treats men as an afterthought. Posterity Health is changing this paradigm with AI-driven diagnostics, telehealth, at-home testing, and access to a network of leading reproductive urologists. By integrating cutting-edge technology with expert clinical care, Posterity Health is modernizing the reproductive healthcare journey at every stage.

"For decades, women have shouldered the burden of fertility treatment. Posterity Health shifts the conversation ensuring that both partners are actively involved in the journey," said Maria D. Toler, Managing Partner at SteelSky Ventures. "By assessing male fertility early on, we can improve overall outcomes and reduce the need for expensive and intrusive treatments."